In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Rapid Micro Biosystems closes $18.6mm Series A

Executive Summary

Rapid Micro Biosystems (formerly Genomic Profiling Systems; microbial detection) took in $18.6mm via its Series A financing led by Kleiner Perkins Caufield & Byers. Other new backers TVM Capital, Quaker BioVentures, and VIMAC Milestone Medica Fund contributed along with five other investors.
Deal Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies